Skip to content
For many women navigating perimenopause or menopause, hormone therapy may be one option for managing symptoms such as hot flashes, night sweats, vaginal dryness, and sleep disturbances. But before beginning treatment, there is another important part of the conversation: your breast health and individual breast cancer risk.
Breast cancer risk isn’t the same for every woman. Your age, personal medical history, family history, breast density, previous breast findings, genetic factors, and other health considerations can all influence your individual risk. Family history is particularly important because certain patterns of breast, ovarian, pancreatic, and prostate cancer may indicate an inherited cancer risk.
Understanding those factors doesn’t automatically determine whether hormone therapy is right or wrong for you. Instead, it gives you and your healthcare provider more information to make an individualized decision about treatment, screening, and long-term health.
Why Breast Health Matters Before Hormone Therapy
Hormone therapy is not a one-size-fits-all treatment. The potential benefits and risks can vary based on your age, health history, type of hormone therapy, and other individual factors. ACOG recommends discussing both personal and family medical history when deciding whether menopausal hormone therapy is appropriate.
Breast health is an important part of that conversation because some breast cancers are hormone-sensitive. The relationship between menopausal hormone therapy and breast cancer risk also differs depending on the type of therapy being used.
For example, ACOG notes that combined estrogen and progestin therapy is associated with a small increased risk of breast cancer. Evidence from the Women’s Health Initiative did not show the same increased breast cancer risk among women who had undergone hysterectomy and received estrogen alone.
This is why a personalized risk assessment matters more than broadly labeling hormone therapy as either “safe” or “unsafe.”
Start With Your Personal and Family History
Before beginning hormone therapy, your provider should understand more than the symptoms you’re experiencing. Your personal and family cancer history can provide important information about whether additional risk assessment or screening may be appropriate.
Tell your provider about a family history of:
- Breast cancer, particularly at younger ages
- Ovarian, fallopian tube, or peritoneal cancer
- Pancreatic cancer
- Prostate cancer
- Male breast cancer
- Known hereditary cancer-related genetic variants
It’s also important to discuss your own history of breast biopsies, abnormal mammograms, breast cancer, ovarian cancer, or other relevant medical conditions.
Family history doesn’t automatically mean you carry an inherited genetic variant or will develop cancer. However, certain family patterns can be a reason to consider genetic counseling and testing.
When Should Women Consider Genetic Testing?
For women with certain personal or family histories, genetic testing can provide additional information about inherited cancer risk.
Although BRCA1 and BRCA2 are among the best-known genes associated with hereditary breast and ovarian cancer, they’re not the only genes involved. Modern multigene panels can evaluate many genetic variants associated with hereditary cancers.
This is something Evolve’s Dr. Mary Martin, MD, FACOG, emphasizes when discussing breast health with women:
“Women with a family history of breast or ovarian cancer have testing available to help determine their lifetime risk of developing breast or ovarian cancer. Testing can be performed using a blood or saliva sample. Understanding that risk can help determine whether additional breast screening may be appropriate.”
One option Dr. Martin discusses with appropriate patients is Myriad Genetics’ MyRisk Hereditary Cancer Test. Myriad currently states that MyRisk evaluates 63 genes associated with 11 hereditary cancers and, for eligible women, can provide five-year and remaining lifetime breast cancer risk information. Testing can be completed using a blood or saliva sample.
Genetic testing isn’t necessary for every woman considering hormone therapy. A healthcare provider or genetic counselor can help determine whether your personal or family history makes testing appropriate.
What Does a Higher Lifetime Breast Cancer Risk Mean for Screening?
Knowing your breast cancer risk can influence more than your hormone therapy conversation. It may also change how you’re screened for breast cancer.
The American Cancer Society recommends that women considered at high risk, including those with an estimated lifetime breast cancer risk of approximately 20% to 25% or greater based mainly on family-history risk models, receive a breast MRI and mammogram every year, typically beginning around age 30.
Importantly, breast MRI does not replace mammography. The two tests can identify different findings, which is why MRI is recommended in addition to mammography for certain high-risk women.
Dr. Martin explains the practical importance of identifying these higher-risk patients:
“If a woman’s lifetime breast cancer risk exceeds 20%, a yearly mammogram alone may not be enough. Additional screening with breast MRI may be recommended.”
The exact timing and screening schedule should be determined by the healthcare professionals managing your breast health based on your individual risk.
Does Hormone Therapy Increase Breast Cancer Risk?
This question deserves more nuance than a simple yes or no.
The relationship between hormone therapy and breast cancer depends on factors including the type of hormones used, duration of treatment, personal health history, and individual risk profile.
Current ACOG guidance states that combined estrogen and progestin therapy is associated with a small increased risk of breast cancer. Estrogen-only therapy has a different risk profile and, in randomized Women’s Health Initiative data among women who previously had a hysterectomy, was not associated with the same increase in breast cancer risk.
The Menopause Society similarly emphasizes that breast cancer risk differs between estrogen-only and combined estrogen-progestogen therapy and may change with duration of use.
That doesn’t mean hormone therapy is inappropriate for every woman with a family history of breast cancer. It means your individual risk factors should be considered alongside the potential benefits of treatment.
Women with a personal history of breast cancer require additional consideration. ACOG states that systemic hormone therapy generally is not recommended for women who have had breast cancer, and treatment decisions in breast cancer survivors should involve appropriate healthcare professionals.
Breast Health Is About More Than a Mammogram
Keeping up with recommended breast cancer screening is important, but breast health also means understanding what is normal for you.
Changes that deserve medical attention can include a new breast or underarm lump, nipple changes or discharge, skin changes, or other new and persistent breast symptoms. Many breast changes are benign, but a healthcare provider should evaluate new or concerning findings rather than waiting until your next routine screening.
Before starting hormone therapy, make sure your provider knows about previous breast imaging, biopsies, abnormal findings, and any new symptoms you’ve noticed. Your screening history can become part of the larger conversation about your health rather than something considered separately from menopause care.
When to Speak With a Provider
If you’re considering hormone therapy for symptoms of perimenopause or menopause, your breast health should be part of the discussion from the beginning. That includes reviewing your personal and family history, understanding whether you’re up to date with appropriate screening, and determining whether additional risk assessment may be appropriate.
At Evolve Telemedicine, our providers take an individualized approach to women’s hormone care. Symptoms are considered alongside health history, risk factors, laboratory findings when appropriate, and personal treatment goals rather than using the same approach for every patient.
For women with a significant family history of breast or ovarian cancer, that conversation may also include whether genetic counseling or hereditary cancer risk testing should be considered.
Book a complimentary consultation to discuss your symptoms, health history, and whether personalized hormone therapy may be appropriate for you.
Frequently Asked Questions
Should I get a mammogram before starting hormone therapy?
Whether you need breast imaging before starting hormone therapy depends on your age, screening history, symptoms, and individual breast cancer risk. Your provider can determine whether you’re up to date with recommended screening and whether additional evaluation is needed before treatment.
Does a family history of breast cancer mean I can’t take hormone therapy?
Not necessarily. Family history is one factor used to evaluate breast cancer risk and treatment decisions. ACOG recommends considering personal and family medical history when deciding whether menopausal hormone therapy is appropriate.
Should I get genetic testing before hormone therapy?
Genetic testing isn’t routinely necessary for every woman considering hormone therapy. However, certain personal or family histories of breast, ovarian, pancreatic, prostate, and related cancers may warrant genetic counseling and testing.
What breast cancer risk requires an MRI?
The American Cancer Society recommends annual breast MRI plus mammography for certain high-risk women, including those with an estimated lifetime breast cancer risk of approximately 20% to 25% or greater based mainly on family-history risk assessment tools. MRI is used in addition to mammography rather than as a replacement.
Does hormone therapy cause breast cancer?
The relationship isn’t the same for every form of hormone therapy. Combined estrogen-progestin therapy has been associated with a small increased breast cancer risk, while estrogen-only therapy has shown a different risk profile. Individual risk, treatment type, and duration all matter.
Can women with dense breasts use hormone therapy?
Breast density is one factor involved in breast cancer risk assessment, but it does not by itself determine whether hormone therapy is appropriate. Your provider can consider breast density alongside your family history, personal history, age, and other risk factors.
Can I take hormone therapy if I’ve had breast cancer?
Systemic hormone therapy generally is not recommended for women with a history of breast cancer. Women experiencing menopause symptoms after breast cancer should discuss treatment options with their oncologist and women’s healthcare provider because recommendations depend on the individual’s cancer and health history.
How often should breast cancer risk be reviewed?
Risk isn’t necessarily static. New diagnoses within your family, changes in your own health, or new breast findings can affect risk assessment. The American Cancer Society recommends reviewing changes in personal and family history over time, and women using hormone therapy should continue discussing their individual risks and benefits with their healthcare provider.
